Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk. - Wikidata - wikimedia - TriplyDB

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

http://www.wikidata.org/entity/Q33905391

about

Enhanced specificity of TPMT*2 genotyping using unidirectional wild-type and mutant allele-specific scorpion primers in a single tube Utility of maternal 6-thioguanine nucleotide levels in predicting neonatal pancytopenia.Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia.Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.Comparison of Direct Sequencing, Real-Time PCR-High Resolution Melt (PCR-HRM) and PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) Analysis for Genotyping of Common Thiopurine Intolerant Variant Alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan Association Between Thiopurine S-Methyltransferase (TPMT) Genetic Variants and Infection in Pediatric Heart Transplant Recipients Treated With Azathioprine: A Multi-Institutional Analysis.The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.

P2860

Q28541963-F48C383E-2956-4A4B-ADEE-88B71321F613 Q36975357-30F65EE8-661C-436B-BAED-449B0431DFBA Q37994062-55CF7E5B-DDA2-458E-80C4-5FD05C00FB49 Q38243174-EB81ECAA-9350-4838-A1A9-E09B4E706B3A Q41008729-F392C64E-38B0-41DE-9C2E-50C11B8F5188 Q49648488-AEA0DC82-785B-45DB-84CD-023B70F7666D Q54222455-B2BACAC0-036C-4CD3-95B3-1E763D3B3306 Q54347571-E1F065C0-2E66-4B5D-9F89-AF92B337B83A

P2860

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

http://www.wikidata.org/entity/Q33905391

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

@ast

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

@en

type

label

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

@ast

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

@en

prefLabel

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

@ast

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

@en

P1433

Q33905391-4DCA3807-2085-45F3-B818-05B969F7EC6E

P1476

Q33905391-F16FAE6E-4180-4B19-9B4E-29CA01B8E8B2

P2093

Q33905391-1617AF3A-1F66-4887-B5DD-545F2C55DA3D

Q33905391-61CEF6E3-9D45-4229-8DFB-BC5568D38671

Q33905391-80045A59-EAF6-4A88-BC36-06B201670760

P2860

Q33905391-0778E6B3-F0FA-4DDB-B3B4-4DB9C63FC67D

Q33905391-0C7FF764-6EEE-4A3F-8711-A0614402A0FE

Q33905391-10A7C55C-1B21-4A36-863D-00AECB548023

Q33905391-12F991AA-1F5A-47CE-8986-2642E2D2560E

Q33905391-274042AE-4FFA-42A0-ADF5-EAB421FC7DB6

Q33905391-2A997B54-2168-4091-9B07-506DE157E318

Q33905391-2C595163-2039-4295-B798-507BB5ECFEE8

Q33905391-2FC67FBC-B1EB-4E3A-90AD-EDF0F1E7A7BF

Q33905391-3A8E9BC4-46BD-432D-A5C7-1C9AF6845F8C

Q33905391-3AA3EF76-EC4D-4B6B-AD4D-F02167996752

P304

Q33905391-2FF94471-63AE-499F-9774-63246B31D2F6

P31

Q33905391-681B8FA1-DA88-4B92-A70F-C229E8EE27F5

P356

Q33905391-E13C6832-42C3-4A5D-A1E9-817BBC0DDE3D

P478

Q33905391-14B05E88-CB2B-4798-9190-6FCFC7208E1B

P577

Q33905391-33BEC431-B4C0-48B0-A86F-17848044A7EF

P698

Q33905391-3FEE6D2A-625A-4C03-8D89-3B8C315A90D2

P932

Q33905391-644A7862-A2EA-4FC3-905B-EA1B7AD2313A

P356

CURRENTS.RRN1236

P1433

P1476

Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk.

@en

P2093

Christine M Nguyen

http://www.w3.org/2001/XMLSchema#string

Joseph D Ma

http://www.w3.org/2001/XMLSchema#string

Margaret A S Mendes

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Pharmacogenetics: from bench to byte--an update of guidelines.

Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain

Assessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs.

Pharmacogenetics of inflammatory bowel disease.

Guidelines for the management of inflammatory bowel disease in adults.

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.

P304

RRN1236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/CURRENTS.RRN1236

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21593964

http://www.w3.org/2001/XMLSchema#string

P932

3094768

http://www.w3.org/2001/XMLSchema#string